Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Immuneering stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IMRX.
You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.
Other companies in Immuneering’s space includes: Renovaro (NASDAQ:RENB), Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), Skye Bioscience (NASDAQ:SKYE) and Gain Therapeutics (NASDAQ:GANX).
Immuneering has a consensus price target of $14.67.
The stock price for Immuneering (NASDAQ: IMRX) is $1.46 last updated April 25, 2025 at 6:31 PM EDT.
There are no upcoming dividends for Immuneering.
Immuneering’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Immuneering.
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.